ENZON PHARMACEUTICALS INC's ticker is ENZN and the CUSIP is 293904108. A total of 4 filers reported holding ENZON PHARMACEUTICALS INC in Q4 2012. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $310,000 | -71.8% | 257,775 | -75.1% | 0.00% | -73.3% |
Q1 2015 | $1,098,000 | -2.4% | 1,036,073 | +0.4% | 0.02% | -6.2% |
Q4 2014 | $1,125,000 | +0.6% | 1,031,923 | -0.3% | 0.02% | +6.7% |
Q3 2014 | $1,118,000 | +3.0% | 1,034,833 | -0.8% | 0.02% | +15.4% |
Q2 2014 | $1,085,000 | +0.5% | 1,043,363 | -0.5% | 0.01% | -7.1% |
Q1 2014 | $1,080,000 | -9.1% | 1,048,423 | +2.4% | 0.01% | -6.7% |
Q4 2013 | $1,188,000 | -31.2% | 1,023,893 | -0.4% | 0.02% | -31.8% |
Q3 2013 | $1,727,000 | -15.9% | 1,027,743 | +0.1% | 0.02% | -15.4% |
Q2 2013 | $2,053,000 | +49.7% | 1,026,723 | +184.5% | 0.03% | +62.5% |
Q1 2013 | $1,371,000 | +357.0% | 360,865 | +432.2% | 0.02% | +300.0% |
Q4 2012 | $300,000 | – | 67,810 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ativo Capital Management LLC | 416,564 | $575,000 | 0.20% |
ALGERT GLOBAL LLC | 124,891 | $150,000 | 0.08% |
Rotella Capital Management, Inc. | 64,910 | $78,000 | 0.06% |
Spark Investment Management LLC | 362,800 | $431,000 | 0.06% |
Icahn Capital | 5,904,863 | $7,086,000 | 0.02% |
GLOBEFLEX CAPITAL L P | 99,954 | $120,000 | 0.02% |
Kovack Advisors, Inc. | 16,050 | $19,000 | 0.01% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 110,202 | $132,000 | 0.01% |
Renaissance Technologies | 3,614,909 | $4,338,000 | 0.01% |
CSS LLC/IL | 158,829 | $191,000 | 0.01% |